Germany· DE-A57-724af29965ce95f4
Bicalutamid Teva
A bicalutamide product containing bicalutamide, registered in Germany by Teva Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Bicalutamide is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BB03 (bicalutamide), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Bicalutamide · ATC L02BB03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bicalutamide costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.21 in Italy to $2.29 in Switzerland — a ×1.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bicalutamide · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.29
- ES Spain$1.61
- FR France$1.42
- IT Italy$1.21
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Bicalutamide
- Manufacturer
- Teva Gmbh
- Country
- Germany (DE)
- ATC code
- L02BB03
- ATC class
- Bicalutamide
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
477 interactions on record for bicalutamide.
Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bicalutamide · interactions on record
477 records
- 82 severe
- 302 moderate
- 15 minor
- 78 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bicalutamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBICALUPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- FinlandBicalutamid ActavisActavis Group PTC ehf
- United KingdomBicalutamide 150mg tabletsKent Pharma (UK) Ltd
- SpainBICALUTAMIDA ACCORD 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- ItalyBICALUTAMIDE AHCLACCORD HEALTHCARE SLU
- BelgiumBicalutamide Accord Healthcare 50 mgAccord Healthcare
- SwedenBicalustad 150 mg Filmdragerad tablettSTADA Arzneimittel AG
- SwitzerlandBicalutamid Sandoz eco
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Androbloc, Bicalutamid +pharma
- Belgium · Bicalutamide Eg, Bicalutamide Sandoz
- Bulgaria · Бикагратис, Бикалутамид Акорд
- Cyprus · Bicalutamide Rafarm, Bikalen
- Czechia · Bicaluplex, Bicalutanorm
- Denmark · Bicalustad, Bicalutamid Bluefish
- Estonia · Bicalutamide Accord, Bicalutamide Teva
- Spain · Bicalutamida Accord, Bicalutamida Almus
- Finland · Bicalutamid Orion, Bicalutamide Accord
- France · Bicalutamide Accord, Bicalutamide Almus
- United Kingdom (Northern Ireland) · Bicalutamide, Bicalutamide Accord Healthcare
- Greece · Bicalut, Bicalutamide Rafarm
- Croatia · Bicaprox, Bikalis
- Hungary · Bicalutamide Pharmacenter, Bilutamid
- Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
- Iceland · Bicalutamid Medical, Bicalutamide Accord
- Italy · Bicalutamide Accord, Bicalutamide Ahcl
- Lithuania · Bicalutamide Accord, Bicalutamide Teva
- Luxembourg · Bicalutamide Eg, Bicalutamide Teva
- Latvia · Bicalutamide Accord, Bicalutamide Teva
- Malta · Bicalutamide Pharmacare
- Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
- Norway · Bicalutamide Accord, Bicalutamide Bluefish
- Poland · Bicalutamide Accord, Binabic
- Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
- Romania · Bicalutamida Accord, Bicalutamidă Accord
- Sweden · Bicalustad, Bicalutamid Sandoz
- Slovenia · Bikalutamid Accord, Bikalutamid Lek
- Slovakia · Bicagelan, Bicalutamid Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad715131-a0ad-4f75-9ea8-9b85926bf976 GET /v1/drugs/ad715131-a0ad-4f75-9ea8-9b85926bf976?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Bicalutamide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about bicalutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.